Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Challenges in Implementation of National Leprosy Eradication Program: Cross-Sectional, Qualitative Study in Three High Endemic Districts of West Bengal, India

Ray S, Das N, Bandyopadhyay K, et al. Ovid Technologies (Wolters Kluwer Health). Indian Journal of Dermatology. 2025;
Download PDF
Publication

An Atypical Presentation of Erythematous Macules Revealing Paucibacillary Leprosy

Baraz S, Baba R, Amraoui M, et al. Oxford University Press (OUP). Clinical and Experimental Dermatology. 2025;
Download PDF
Publication

Association between MBL2 gene polymorphism and protection against leprosy in a population of northeastern brazil: a case-control study

Nogueira KRC, de Almeida Freitas H, da Paz MNVT, et al. Springer Science and Business Media LLC. Scientific Reports. 2025; 15 (1) : 1-10.
Download PDF
Publication

Quantitative lateral flow strip assays as User-Friendly Tools To Detect Biomarker Profiles For Leprosy

van Hooij A, Tjon Kon Fat EM, Richardus R, et al. Springer Science and Business Media LLC. Scientific Reports. 2016; 6 (1) : 1-11.
Download PDF
Publication

The potential role of artificial intelligence in the clinical management of Hansen’s disease (leprosy)

Deps PD, Yotsu R, Furriel BCRS, et al. Frontiers Media SA. Frontiers in Medicine. 2024;
Download PDF
Publication

Sociocultural and structural determinants of healthcare-seeking of people affected by leprosy in Sierra Leone’s Western area: a qualitative study

Asboeck A, Kallon LH, Schlumberger F, et al. BioMed Central Ltd. Tropical Medicine and Health. 2025;
Download PDF
Publication

High Resolution Nerve Ultrasound in the Diagnosis of Pure Neuritic Leprosy

Roy U, Panwar A, Cartwright MS, et al. Wiley. Journal of Clinical Ultrasound. 2025;
Download PDF
Publication

Decoding leprosy: immune response, clinical manifestations and emerging diagnostic approaches

Serrano-Coll H, Restrepo-Rivera L, Cuadros-Urrego Y, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2025;
Download PDF
Publication

Accuracy of the newly manufactured multiplex XGEN MASTER LEPRAE molecular kit and the point-of-care Bioclin FAST ML FLOW test for case definition and early diagnosis of leprosy among household contacts

Brandão JG, de Macedo AC, Sousa GJB, et al. Elsevier BV. Diagnostic Microbiology and Infectious Disease. 2025; 113 (2) : 116929.
Download PDF
Publication

Crescentic Glomerulonephritis in a 65-year-old Male Patient with Lepromatous Leprosy: Case Report

Bhutani P, Kumar A, Dhar M, et al. Hind Kusht Nivaran Sangh. Indian J Lepr. 2025;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD